Article citationsMore >>

Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology. 2005;41:1383-1390.

has been cited by the following article:

Article

Post Vaccination Evaluation of Anti-HBsAg Antibody Titers among Haemodialysis Patients

1Department of Microbiology, Kamineni Academy of Medical Sciences & Research Centre, L.B.Nagar, Hyderabad, Telangana, India

2Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India


American Journal of Microbiological Research. 2016, Vol. 4 No. 2, 64-67
DOI: 10.12691/ajmr-4-2-4
Copyright © 2016 Science and Education Publishing

Cite this paper:
Raj kumar HRV, Ramahrishna Devaki, Venkataramana Kandi. Post Vaccination Evaluation of Anti-HBsAg Antibody Titers among Haemodialysis Patients. American Journal of Microbiological Research. 2016; 4(2):64-67. doi: 10.12691/ajmr-4-2-4.

Correspondence to: Venkataramana  Kandi, Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India. Email: ramana_20021@rediffmail.com

Abstract

Hepatitis B virus (HBV) is the second most common viral infection which poses threat of infection among health care workers and those individuals treated for various debilitated conditions in hospital settings. Patients undergoing haemodialysis are at a greater risk of acquiring HBV infection. Although HBV vaccination has been in use for almost three decades, it is not completely certain about its efficacy in long-term protection. Few studies in the past have emphasized the need for evaluation of anti-HBsAg antibody titers among high risk groups that include patients undergoing haemodialysis. Studies in the past have also noted that few vaccinated group do not respond to HBV vaccine and that few other group of vaccinated individuals develop inadequate antibody titers. The present study evaluated the antibody titers among haemodialysis patients and health care workers.

Keywords